机构

• 上海药物研究所 [9]
• 金属研究所 [8]

采集方式

• OAI收割 [17]

内容类型

• 期刊论文 [17]

发表日期

• 2020 [1]
• 2016 [3]
• 2015 [2]
• 2014 [2]
• 2013 [5]
• 2012 [1]
• 更多

学科主题

筛选

浏览/检索结果: 共17条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序作者升序作者降序 Synthesis of triazolotriazine derivatives as c-Met inhibitors 期刊论文  OAI收割 MOLECULAR DIVERSITY, 2020, 页码: 8 作者:  Guo, Yuting;  Peng, Xia;  Ji, Yinchun;  Zhang, Yitong;  Ding, Jian   |  收藏  |  浏览/下载：51/0  |  提交时间：2020/12/24 Receptor tyrosine kinase  c-Met  Triazolotriazine  SAR  Cellular potency   Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707 作者:  Liu, Tong-chao;  Peng, Xia;  Ma, Yu-chi;  Ji, Yin-chun;  Chen, Dan-qi   |  收藏  |  浏览/下载：32/0  |  提交时间：2019/01/08 c-Met inhibitors  hepatocyte growth factor receptor  imidazo[1,2-a]pyridine  anticancer agents  drug discovery   Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707 作者:  Liu Tongchao;  Peng Xia;  Ma Yuchi;  Ji Yinchun;  Chen Danqi   |  收藏  |  浏览/下载：33/0  |  提交时间：2021/02/02 RECEPTOR TYROSINE KINASE  INVASIVE GROWTH  SCATTER FACTOR  CANCER  DOCKING  c-Met inhibitors  hepatocyte growth factor receptor  imidazo1,2-apyridine  anticancer agents  drug discovery   Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707 作者:  Liu Tongchao;  Peng Xia;  Ma Yuchi;  Ji Yinchun;  Chen Danqi   |  收藏  |  浏览/下载：52/0  |  提交时间：2021/02/02 RECEPTOR TYROSINE KINASE  INVASIVE GROWTH  SCATTER FACTOR  CANCER  DOCKING  c-Met inhibitors  hepatocyte growth factor receptor  imidazo1,2-apyridine  anticancer agents  drug discovery   Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors 期刊论文  OAI收割 ACS MEDICINAL CHEMISTRY LETTERS, 2015, 卷号: 6, 期号: 5, 页码: 507-512 作者:  Li, Chunpu;  Ai, Jing;  Zhang, Dengyou;  Peng, Xia;  Chen, Xi   |  收藏  |  浏览/下载：28/0  |  提交时间：2019/01/08 Receptor tyrosine kinase  c-Met inhibitor  imidazo[1,2-a]pyridine  metabolic stability   Design, Synthesis and Pharmacological Evaluation of Novel 4-Phenoxyquinoline Derivatives as Potential Antitumor Agents 期刊论文  OAI收割 CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2015, 卷号: 31, 期号: 5, 页码: 746-755 作者:  Hu Hao;  Jiang Mingyan;  Xie Lijun;  Hu Gang;  Zhang Cuirong   |  收藏  |  浏览/下载：22/0  |  提交时间：2021/02/02 MET KINASE INHIBITORS  GROWTH-FACTOR RECEPTOR  C-MET  6,7-DISUBSTITUTED-4-PHENOXYQUINOLINE DERIVATIVES  BIOLOGICAL EVALUATION  DISCOVERY  MOIETY  BEARING  IDENTIFICATION  4-Phenoxyquinoline derivative  Cytotoxic activity  3-Amino-2-cyano-acrylamide   SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo 期刊论文  OAI收割 CANCER LETTERS, 2014, 卷号: 351, 期号: 1, 页码: 143-150 作者:  Wang, Lu;  Ai, Jing;  Shen, Yanyan;  Zhang, Haotian;  Peng, Xia   |  收藏  |  浏览/下载：25/0  |  提交时间：2019/01/08 c-Met  SOMCL-863  Receptor tyrosine kinase  Cancer  Angiogenesis   Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2014, 卷号: 35, 期号: 1, 页码: 89-97 作者:  He, Chang-xi;  Ai, Jing;  Xing, Wei-qiang;  Chen, Yi;  Zhang, Hao-tian   |  收藏  |  浏览/下载：157/0  |  提交时间：2019/01/08 human cancer  anticancer drug  Yhhu3813  c-Met  receptor tyrosine kinase  xenograft nude mouse model   Energetic factors determining the binding of type I inhibitors to c-Met kinase: experimental studies and quantum mechanical calculations 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2013, 卷号: 34, 期号: 11, 页码: 1475-1483 作者:  Yu, Zhe;  Ma, Yu-chi;  Ai, Jing;  Chen, Dan-qi;  Zhao, Dong-mei   |  收藏  |  浏览/下载：36/0  |  提交时间：2019/01/08 receptor tyrosine kinase  type I c-Met inhibitor  cancer  quantum chemistry  protein-ligand interaction  symmetry-adapted perturbation theory (SAPT)   Synthesis and biological evaluation of 2-amino-5-aryl-3-benzylthiopyridine scaffold based potent c-Met inhibitors 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 卷号: 21, 期号: 21, 页码: 6804-6820 作者:  Zhang, Dengyou;  Zhang, Xiaowei;  Ai, Jing;  Zhai, Yun;  Liang, Zhongjie   |  收藏  |  浏览/下载：23/0  |  提交时间：2019/01/08 Receptor tyrosine kinase  c-Met  2-Amino-5-aryl-3-benzylthiopyridine